John Richards is Of Counsel and has more than four decades of patent experience.
John specializes in chemical and biochemical patent matters including drafting and prosecution of patent applications in these fields in the United States, Europe and abroad. John handled the global patenting and licensing for the groundbreaking Alzheimer’s Disease drug known as Razadyne in the U.S and Reminyl internationally.
With respect to Europe, he handles matters for clients of the firm’s London offices before both the UK Intellectual Property Office and the European Patent Office (EPO). He is also widely experienced in the negotiation and drafting of patent and know-how license agreements.
John started work in the patent profession in the patent department of the British chemical company Albright & Wilson in 1966. He joined Ladas & Parry in 1973, becoming a partner in 1982.
He is the general editor of Legal Aspects of Introducing Products to the United States (Kluwer 1988) and co-author of Intellectual Property and the Internal Market of the European Community (Graham & Trotman 1993).
John is an adjunct professor at Fordham University School of Law. He has written and spoken frequently on international intellectual property issues, especially in the fields of patents and copyrights in the United States, Canada, India and East Asia.
In his spare time, John enjoys teaching.